NCT00574886View on ClinicalTrials.gov

Idiotype Vaccine After Chemotherapy & Stem Cell Transplantation in Lymphoma With Failed Induction Chemotherapy

NACompletedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

August 3, 2000

Primary Completion Date

March 1, 2002

Study Completion Date

April 15, 2008

Conditions
Lymphoma
Interventions
BIOLOGICAL

Id-KLH

Idiotype vaccine - .5mg recombinant idiotype immunoglobulin protein given subcutaneously for a total of five administrations over 6 months.

Trial Locations (1)

68198

Unversity of Nebraska Medical Center, Omaha

Sponsors

Collaborators (1)

Genitope Corporation
All Listed Sponsors
collaborator

Genitope Corporation

INDUSTRY

lead

University of Nebraska

OTHER

NCT00574886 - Idiotype Vaccine After Chemotherapy & Stem Cell Transplantation in Lymphoma With Failed Induction Chemotherapy | Biotech Hunter | Biotech Hunter